SEC Form 4 · accession 0001127602-17-022504
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin E Lofton
Director
Period of report
Jun 29, 2017
Accepted (ET)
Jul 3, 2017 · 1:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF1,F2,F3 | $0.00 | Jun 29, 2017 | A | 141 | A | — | — | Common Stock | 141 | 19,290 | D |
Explanation of responses
- F1Each share of phantom stock is the economic equivalent of one share of Gilead common stock.
- F2Phantom shares accrued under dividend equivalent rights, which are settled in shares and distributed with the phantom stock units to which they relate.
- F3The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.